NPHLA Daily — October 8, 2026

Good morning. Here is what changed across metabolic medicine, pharmacy regulation, aesthetics and healthcare technology since yesterday — every item linked to its source.

Top development today

What changed today in Aesthetics & Longevity: 2 trial updates, 1 new study

NPHLA tracked 3 new official records on this desk today: 1 new study, 2 trial updates. First: New research in Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery: “Efficacy of platelet-rich plasma versus growth factor concentrate in…

Metabolic signal

What changed today in Metabolic: 2 new studies

NPHLA tracked 2 new official records on this desk today: 2 new studies. First: New research in Diabetes, obesity & metabolism: “Weight Loss or Muscle Loss? Cellular Mechanisms and Clinical Strategies for Preserving Lean Mass During GLP-1-Based Therapy”.

Regulatory signal

What changed today in Regulatory: 1 recall record

NPHLA tracked 1 new official record on this desk today: 1 recall record. First: Recall: Leader Formulas, LLC. Issues Voluntary Nationwide Recall of RAPTURE Preworkout Due to the Presence of 1,3-Dimethylamylamine (DMAA) — reason given: not stated (firm: not stated).

Aesthetics & Longevity signal

New trial registered: Oral Minoxidil With or Without a Multifactorial Drinkable Nutraceutical in Female Pattern Hair Loss: a Retrospective Study

Olistic Research Labs S.L.. Conditions: Female Pattern Hair Loss; Female Pattern Hair Loss, Androgenic Alopecia. Interventions: Oral low-dose Minoxidil; Drinkable multifactorial food supplement containing vitamins, minerals, plant…

AI & Technology signal

What changed today in AI & Technology: 1 new study

NPHLA tracked 1 new official record on this desk today: 1 new study. First: New research in Research in social & administrative pharmacy : RSAP: “Large language models in pharmacist-led direct patient care: A rapid review of published evaluations”.

One thing worth watching

Comments close: Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and…

October 29, 2026 — verified from the Federal Register comments_close_on.

5 things to know

Compiled by NPHLA Intelligence from published briefings and official records. Professional information only — not medical or legal advice. Our standards.